Padmanaban, Veena http://orcid.org/0000-0002-4810-2597
Grasset, Eloise M.
Neumann, Neil M.
Fraser, Andrew K. http://orcid.org/0000-0001-5266-6849
Henriet, Elodie
Matsui, William
Tran, Phuoc T.
Cheung, Kevin J.
Georgess, Dan http://orcid.org/0000-0003-3075-4527
Ewald, Andrew J. http://orcid.org/0000-0002-1964-0740
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA212007, U54CA2101732, 3P30CA006973, U01CA217846, 3P30CA006973)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Burroughs Wellcome Fund (1013355.01)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (5T32GM007309, 5T32GM007309)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Susan G. Komen (PDF15332336)
Article History
Received: 25 June 2019
Accepted: 16 April 2020
First Online: 20 July 2020
Competing interests
: A.J.E. and K.J.C. have a patent related to the use of keratin-14 as a biomarker for invasive cancer cell populations. A.J.E. and V.P. have a patent related to the use of antibodies for cancer therapy. A.J.E.’s spouse is an employee of Immunocore.